Blood Sample Collection in Geriatric Patients

Sponsor

Saglik Bilimleri Universitesi (Other)

Overall Status

Completed

CT.gov ID

NCT05580965

Collaborator

(none)

164

Enrollment

Location

Arms

7.5

Actual Duration (Months)

21.9

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study aimed to evaluate the effect of different durations of a specific pressure applied after blood collection on the development of ecchymosis in geriatric patients using oral and subcutaneous anticoagulants.

Condition or Disease	Intervention/Treatment	Phase
Venipuncture Site Bruise	Other: 20 N pressure for 1 minute Other: 20 N pressure for 3 minute Other: 20 N pressure for 5 minute	N/A

Detailed Description

The research sample consisted of patients hospitalized in the Geriatrics Clinic of a city hospital. This study aimed to evaluate the effect of different durations of a specific pressure applied after blood collection on the development of ecchymosis in geriatric patients using oral and subcutaneous anticoagulants. In this study, whether ecchymosis developed at the 24th, 48th and 72nd hours after the blood collection procedure was evaluated.

Study Design

Study Type:

Interventional

Actual Enrollment :

164 participants

Allocation:

Randomized

Intervention Model:

Crossover Assignment

Masking:

Single (Investigator)

Primary Purpose:

Prevention

Official Title:

The Effect of Duration of Pressure Applied After Blood Sample Collection on the Development of Ecchymosis in Geriatric Patients Using Oral and Subcutaneous Anticoagulants: A Randomized Controlled Trial

Actual Study Start Date :

Oct 30, 2021

Actual Primary Completion Date :

Jun 15, 2022

Actual Study Completion Date :

Jun 15, 2022

Arms and Interventions

Arm	Intervention/Treatment
No Intervention: control group Routine procedure
Experimental: Group A 1 min pressure applied	Other: 20 N pressure for 1 minute After blood collection, 20 N pressure applied for 1 minute
Experimental: Group B 3 min pressure applied	Other: 20 N pressure for 3 minute After blood collection, 20 N pressure applied for 3 minute
Experimental: Group C 5 min pressure applied	Other: 20 N pressure for 5 minute After blood collection, 20 N pressure applied for 5 minute

Outcome Measures

Primary Outcome Measures

number of participants with ecchymosis developed. [at the 24 th hours]
In this study, whether ecchymosis developed at the 24th, 48th, and 72nd hours after the blood collection procedure was evaluated.
number of participants with ecchymosis developed. [at the 48 th hours]
In this study, whether ecchymosis developed at the 24th, 48th, and 72nd hours after the blood collection procedure was evaluated.
number of participants with ecchymosis developed. [at the 72 nd hours]
In this study, whether ecchymosis developed at the 24th, 48th, and 72nd hours after the blood collection procedure was evaluated.

Eligibility Criteria

Criteria

Ages Eligible for Study:

65 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

patients aged 65 years and over
who voluntarily agreed to participate in the study
who used oral (Rivaroxaban 10-15-20 mg, Dabigatran, 75-110-150 mg, Apixaban 2.5-5 mg) and subcutaneous (Enoxaparin sodium 6000-4000 anti-Xa IU/0.6-0.4 ml) anticoagulants
who were literate in Turkish
who were scheduled for blood collection
who would undergo blood collection from the antecubital site with vacutainer

Exclusion Criteria:

patients with communication problems
patients with hematoma, ecchymosis, and scarring in the antecubital site
patients who would be discharged before 72 hours
patients with coagulation disorders

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Tulay Basak	Ankara		Turkey	06010

Sponsors and Collaborators

Saglik Bilimleri Universitesi

Investigators

Principal Investigator: Tülay Başak, Saglik Bilimleri Universitesi

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Tulay Basak, Professor, Saglik Bilimleri Universitesi

ClinicalTrials.gov Identifier:

NCT05580965

Other Study ID Numbers:

First Posted:

Oct 14, 2022

Last Update Posted:

Oct 14, 2022

Last Verified:

Oct 1, 2022

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Study Results

No Results Posted as of Oct 14, 2022